Beutel, Goodman & Co’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-264,854
Closed -$25.7M 70
2019
Q1
$25.7M Sell
264,854
-336,153
-56% -$40.9M 0.19% 50
2018
Q4
$51M Sell
601,007
-1,614,357
-73% -$180M 0.43% 43
2018
Q3
$184M Sell
2,215,364
-279,164
-11% -$27.9M 1.33% 19
2018
Q2
$162M Buy
2,494,528
+327,484
+15% +$26.9M 1.19% 20
2018
Q1
$146M Sell
2,167,044
-248,556
-10% -$20M 1.1% 24
2017
Q4
$163M Buy
2,415,600
+110,241
+5% +$9.38M 1.11% 27
2017
Q3
$158M Sell
2,305,359
-258,998
-10% -$21.2M 1.2% 27
2017
Q2
$163M Buy
2,564,357
+311,417
+14% +$25.4M 1.47% 19
2017
Q1
$161M Buy
+2,252,940
New +$180M 1.42% 20
2016
Q3
Sell
-1,723,716
Closed -$104M 29
2016
Q2
$104M Buy
+1,723,716
New +$130M 1.07% 25
2015
Q3
Sell
-1,950,294
Closed -$139M 26
2015
Q2
$139M Sell
1,950,294
-29,670
-1% -$2.26M 1.17% 23
2015
Q1
$113M Buy
1,979,964
+10,354
+0.5% +$737K 1.09% 26
2014
Q4
$112M Buy
1,969,610
+4,113
+0.2% +$278K 1% 26
2014
Q3
$109M Buy
+1,965,497
New +$124M 0.95% 27

Other funds holding LLY

Beutel, Goodman & Co's LLY Position: Q2 2019 in Review

Beutel, Goodman & Co sold out of Eli Lilly (LLY) in Q2 2019, closing a stake of 264,854 shares — an estimated $25.7M sold.

Beutel, Goodman & Co first reported a position in LLY in Q3 2014 and held it in 14 quarters. The position peaked at $184M in Q3 2018. 1,516 funds tracked by Wall St. Rank hold LLY as of Q2 2019.

  • Beutel, Goodman & Co reported no remaining Eli Lilly position as of Q2 2019 after selling out during the quarter.
  • Beutel, Goodman & Co sold 264,854 Eli Lilly shares in Q2 2019, an estimated $25.7M.
  • Beutel, Goodman & Co first reported a position in Eli Lilly in Q3 2014 and held it in 14 quarters.
  • Beutel, Goodman & Co's Eli Lilly position peaked at $184M in Q3 2018.
  • 1,516 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2019.

Based on Beutel, Goodman & Co's 13F filing for Q2 2019, filed 15 Aug 2019.